Or click and collect!
Or click and collect!
If you have an existing health condition and you vape, or are thinking about switching from cigarettes to vaping, the risk picture is more nuanced than a general population assessment. Here is an honest condition-by-condition overview.
The general population risk assessment for vaping, substantially less harmful than smoking, not risk-free, applies differently when an existing health condition is present. Some conditions make specific aspects of vaping's health effects more significant. The most important principle is: if you have a health condition and you vape, your clinical team should know. This is not about judgement, it is about ensuring your condition is managed with all relevant variables accounted for.
Nicotine raises heart rate and blood pressure through adrenaline release and vasoconstriction. For people with coronary artery disease, arrhythmia, heart failure or hypertension, this additional cardiovascular load is clinically significant. If you are a smoker with a cardiovascular condition, switching to vaping removes the far greater cardiovascular burden of carbon monoxide and combustion-product-driven coronary inflammation, this is likely to be a net benefit. However the nicotine-mediated cardiovascular effects remain and your cardiologist needs to know you vape. Reducing nicotine strength progressively is particularly important in this group.
Asthmatic airways are hyperreactive and more prone to triggering on inhaled irritants. Vaping can trigger airway reactivity in asthmatic individuals through PG irritation and flavouring compounds. If you have asthma and vape, your GP or respiratory specialist should know. Higher-VG liquids and avoiding known trigger flavour compounds (menthol, cinnamon) can reduce airway reactivity. For COPD patients who smoke, switching to vaping removes the ongoing combustion-product damage that drives COPD progression, though the structural damage already done is not reversible. All COPD patients considering vaping should do so under GP supervision.
Nicotine impairs insulin sensitivity and triggers cortisol release, both of which elevate blood glucose. For people with type 1 or type 2 diabetes, vaping can affect blood sugar readings and complicate glycaemic management. For diabetic smokers, switching to vaping removes the additional cardiovascular risk of smoking, a significant benefit for a group already at elevated cardiac risk. But diabetes management needs to account for nicotine's metabolic effects. Tell your diabetes care team you vape.
Nicotine's effects on mood, anxiety and the dopamine system are particularly relevant for people with depression, anxiety disorders or other mental health conditions. The dependency loop, using nicotine to relieve withdrawal-induced anxiety and low mood, can become deeply entangled with mental health management. Nicotine is not an effective long-term treatment for anxiety or depression and its withdrawal effects can worsen both. People managing mental health conditions who use nicotine should discuss this with their mental health team, particularly when planning any reduction in nicotine intake.
Nicotine use during pregnancy is not appropriate for any condition. The risks to fetal development from nicotine are well-documented regardless of delivery method. Pregnant women who are struggling to stop nicotine should speak to their midwife about supported cessation, NHS Stop Smoking services provide priority access for pregnant women.
We will always direct you to your clinical team for condition-specific advice and help with everything else we can.
To find our Coventry store, visit our Vape Shop Coventry page.
Our Health guide covers condition-specific vaping questions alongside the broader health evidence base, always with the recommendation to involve your clinical team.
Find more condition-specific and health guides in our Health guide.
We will help with product choices and practical questions once your GP is in the picture.